Search over 3,000 reports

    Cervical Cancer- Epidemiology Forecast to 2023

    Cervical Cancer- Epidemiology Forecast to 2023
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 40
    Geography: Global
    Delivery Timeline: 48 hrs
    SKU: DIEI0009
    DelveInsight's "Cervical Cancer- Epidemiology Insights-2023" Reports provides an overview of the disease and the global historical and forecasted epidemiological data of the Cervical Cancer for the 7 major markets- United States, EU5(Germany, France, Italy, Spain and United Kingdom) and Japan for 2013-2023. According to Publisher, the incidence rate for Cervical Cancer and its subtypes from 2015 to 2023 will remain the same. However, the number of incident cases is expected to increase due to the increase in the total female population.
    Cervical Cancer occurred due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes. Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
    Key Coverage and Benefits

    Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

    The Report covers the detailed global historical and forecasted epidemiological data covering 7MM from 2013-2023.
    1. Introduction
    2. Disease Overview
    • Types of Cervical cancer
    • Staging of Cervical cancer
    • Pathophysiology
    • Etiology
    • Risk Factors
    • Diagnosis
    3. Epidemiology and Patient Population
    4. United States
    • Assumptions and Rationale
    • Incident Cases of Cervical Cancer in United States
    • Incident Cases of Cervical Cancer Diagnosed by Cancer Stage
    5. Europe
    5.1 United Kingdom (UK)
    • Assumptions and Rationale
    • Incident Cases of Cervical Cancer in United Kingdom (UK)
    5.2 Germany (DE)
    • Assumptions and Rationale
    • Incident Cases of Cervical Cancer in Germany (DE)
    5.3 Italy (IT)
    • Assumptions and Rationale
    • Incident Cases of Cervical Cancer in Italy (IT)
    5.4 France (FR)
    • Assumptions and Rationale
    • Incident Cases of Cervical Cancer in France (FR)
    5.6 Spain (SP)
    • Assumptions and Rationale
    • Incident Cases of Cervical Cancer in Spain (SP)
    6. Japan (JP)
    • Assumptions and Rationale
    • Incident Cases of Cervical Cancer in Japan (JP)
    7. Appendix
    8. Report Methodology
    9. Consulting Services
    10. Disclaimer
    11. About DelveInsight
    Table 1: Incident Cases of Cervical Cancer in United States (2013-2023)
    Table 2: Incident Cases of Cervical Cancer diagnosed by Cancer Stage, in United States (2013-2023)
    Table 3: Incident Cases of Cervical Cancer in United Kingdom (2013-2023)
    Table 4: Incident Cases of Cervical Cancer in Germany (2013-2023)
    Table 5: Incident Cases of Cervical Cancer in Italy (2013-2023)
    Table 6: Incident Cases of Cervical Cancer in France (2013-2023)
    Table 7: Incident Cases of Cervical Cancer in Spain (2013-2023)
    Table 8: Incident Cases of Cervical Cancer in Japan (2013-2023)
    Figure 1: Pathophysiology of Cervical Cancer, 2017
    Figure 2:Risk Factors of Cervical Cancer, 2017
    Figure 3: Incident Cases of Cervical Cancer in United States (2013-2023)
    Figure 4: Incident Cases of Cervical Cancer diagnosed by Cancer Stage, in United States (2013-2023)
    Figure 5: Incident Cases of Cervical Cancer in United Kingdom (2013-2023)
    Figure 6: Incident Cases of Cervical Cancer in Germany (2013-2023)
    Figure 7: Incident Cases of Cervical Cancer in Italy (2013-2023)
    Figure 8: Incident Cases of Cervical Cancer in France (2013-2023)
    Figure 9: Incident Cases of Cervical Cancer in Spain (2013-2023)
    Figure 10: Incident Cases of Cervical Cancer in Japan (2013-2023)


    Cervical Cancer Disease Overview

    Cervical Cancer Prevalence

    Cervical Cancer Incidence

    Cervical Cancer Risk Factors

    Cervical Cancer Epidemiology

    Cervical Cancer Patient Populations

    Cervical Cancer Diagnosed Patients

    Cervical Cancer Forecast

    Cervical Cancer Epidemiology Forecast

    Cervical Cancer Treated patients/population

    • Single User License
      (20% Off)
      $2,750.00
    • Site License
      (30% Off)
      $5,500.00
    • Global License
      (40% Off)
      $8,250.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap